{
    "eid": "2-s2.0-85082146092",
    "title": "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)",
    "cover-date": "2020-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "Coronavirus",
        "Emerging threat",
        "Immunotherapy",
        "Infectious diseases",
        "Monoclonal antibody",
        "Viruses",
        "Zoonoses"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Konlavat Siriwattananon",
        "Kittikhun Wangkanont",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 356,
    "ref-count": 78,
    "ref-list": [
        "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China",
        "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia",
        "Return of the coronavirus: 2019-nCoV",
        "The molecular biology of coronaviruses",
        "Bats and Coronaviruses",
        "Structure, function, and evolution of coronavirus spike proteins",
        "Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China",
        "Novel Wuhan (2019-nCoV) coronavirus",
        "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges",
        "Potential interventions for novel coronavirus in China: A systematic review",
        "Coronaviruses: Important emerging human pathogens",
        "Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee",
        "Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital",
        "Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?",
        "Cross-reactive antibodies in convalescent SARS patients\u2019 sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests",
        "The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis",
        "Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: A study protocol",
        "Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants",
        "Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: Rationale and mechanisms of action",
        "Monoclonal antibodies for prophylactic and therapeutic use against viral infections",
        "The growth and potential of human antiviral monoclonal antibody therapeutics",
        "A randomized, controlled trial of ZMapp for Ebola Virus infection",
        "Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A",
        "Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117",
        "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC",
        "MERS-CoV spike protein: A key target for antivirals",
        "From SARS to MERS, thrusting coronaviruses into the spotlight",
        "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus",
        "Structure of SARS coronavirus spike receptor- binding domain complexed with receptor",
        "Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS",
        "Neutralizing human monoclonal antibodies to Severe acute respiratory syndrome coronavirus: Target, mechanism of action and therapeutic potential",
        "Structure and function of immunoglobulins",
        "Therapeutic proteins",
        "Therapeutic antibodies for infectious diseases",
        "Antigen production in plant to tackle infectious diseases flare up: The case of SARS",
        "Plant-derived monoclonal antibodies for prevention and treatment of infectious disease",
        "Innovation in plant-based transient protein expression for infectious disease prevention and preparedness",
        "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development",
        "Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association",
        "Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology",
        "Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of Severe acute respiratory syndrome coronavirus",
        "Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants",
        "Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets",
        "Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies",
        "Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody",
        "Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of Severe acute respiratory syndrome coronavirus",
        "Development and characterization of a Severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice",
        "Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing",
        "Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion",
        "Antibodies and vaccines against Middle East respiratory syndrome coronavirus",
        "A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective",
        "Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein",
        "Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections",
        "Structural definition of a unique neutralization epitope on the Receptor-binding domain of MERS-CoV spike glycoprotein",
        "Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27",
        "A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein",
        "Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets",
        "Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection",
        "Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies",
        "Evaluation of candidate vaccine approaches for MERS-CoV",
        "Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen",
        "Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape",
        "A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice",
        "Ultrapotent human neutralizing antibody repertoires against Middle East respiratory syndrome coronavirus from a recovered patient",
        "Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset",
        "Middle East respiratory syndrome coronavirus (MERSCoV) causes transient lower respiratory tract infection in rhesus macaques",
        "Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein",
        "Structural Definition of a Neutralization-sensitive Epitope on the MERS-CoV S1-NTD",
        "Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis",
        "Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R",
        "Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain",
        "Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody",
        "Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains",
        "Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26",
        "Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Second Century Fund",
        "Chulalongkorn University"
    ]
}